Tysabri (natalizumab) is a powerful medication used primarily to treat multiple sclerosis (MS), especially in patients with relapsing forms of the disease. Because MS treatment often involves multiple drugs, understanding how Tysabri interacts with other MS medications is crucial for…
Tysabri (natalizumab) is a medication primarily approved and used for treating relapsing forms of multiple sclerosis (MS), such as relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS). Its use in progressive MS, especially the non-active or purely progressive forms,…
Tysabri (natalizumab) is a medication used to treat multiple sclerosis (MS), particularly relapsing forms of the disease. It works by blocking certain immune cells from crossing into the brain and spinal cord, thereby reducing inflammation and damage to nerve fibers.…
The risk of progressive multifocal leukoencephalopathy (PML) with Tysabri (natalizumab) is a serious and well-recognized concern in the treatment of multiple sclerosis (MS). PML is a rare but often fatal brain infection caused by the reactivation of the JC virus…
Tysabri (natalizumab) is a medication primarily used to treat multiple sclerosis (MS) and Crohn’s disease by modulating the immune system. While it is effective in reducing MS relapses and slowing disease progression, it carries a serious risk of causing brain…
Tysabri (natalizumab) is a medication primarily used to treat multiple sclerosis (MS) and Crohn’s disease by modifying the immune system to reduce inflammation and disease activity. While it can be highly effective, it also carries a range of potential side…
Gilenya (fingolimod) is a medication primarily used to treat multiple sclerosis by modulating the immune system. When it comes to whether Gilenya interacts with birth control, the current understanding is that **no formal interaction studies have been conducted specifically between…
Gilenya, whose generic name is fingolimod, is a medication primarily used to treat relapsing forms of multiple sclerosis (MS). It works by modulating the immune system, specifically by reducing the number of certain white blood cells called lymphocytes in the…
Gilenya (fingolimod) is a medication primarily used to treat multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. One common concern among patients starting or taking Gilenya is whether it causes changes in body weight. The question…
Missing a dose of Gilenya (fingolimod) can have important implications because this medication is used to manage multiple sclerosis (MS) by modulating the immune system. If you miss one or more doses, it may affect how well the drug controls…